Prior to joining Sanderling, Dr. Mills served as the Corporate Vice President of New Business Development and Chief Scientific Officer of Target Therapeutics, a medical device company that was acquired by Boston Scientific for $1.2 billion in 1997. He also served as the Director for Prograft Medical, a Target affiliate. Prior to joining Target in 1994, Dr. Mills served as Director of Business Development and Advanced Research and Development in the Interventional Cardiology Division of Baxter Healthcare. Dr. Mills' academic appointments include service as the Director of the Artificial Heart Program at the University of California, Irvine Medical Center and membership in the University of California, San Francisco Radiology Department.

Dr. Mills received his Ph.D. in Bioengineering from the University of California, Berkeley and San Francisco School of Medicine; his M.S. in Electrical Engineering and Computer Science from the University of California, Berkeley; and his B.S. in Electrical Engineering from the University of Colorado, Boulder.

Nathan Hamilton, Board Director
Nathan Hamilton is a founder and Managing Director of Archangel BioVentures, LLC, which specializes in entrepreneurial biomedical investments. Mr. Hamilton has played an active management or advisory role in several biomedical startups and buyouts including Biolog, Dynatherm Medical, Juvenon, Metrigen, Micro Fluidic Systems, and Operon Technologies. As President of Operon, he built the business into the number one synthetic DNA supplier worldwide and executed a sale to QIAGEN. He currently serves on the board of five companies.

Mr. Hamilton received his B.A. in Physics from the University of California, Berkeley and his Masters of Business Administration from Harvard University Graduate School of Business.

Scott Christensen, Board Director, Dynatherm President and Chief Executive Officer
Scott Christensen brings over 28 years' experience in the medical device industry to the company. Before joining Dynatherm in early 2005, Mr. Christensen served as EVP Sales, Marketing & Business Development at Hoana Medical. This early stage venture is developing a "smart bed" coverlet for the early detection of a deteriorating clinical condition of hospitalized patients in the med/surg units using proprietary, non-contact measuring technology. Prior to Hoana, he served as President of now public Oridion Medical, a leader in respiratory monitoring in the OR / ICU and other healthcare environments. Additionally, Mr. Christensen served in various management roles at Nellcor Puritan Bennett, CDI 3M HealthCare and Medtronic Physio-Control. Mr. Christensen received his B.S. in Chemistry from the University of California, Davis and his Masters of Business Administration from the Graduate School of Management - University of California, Irvine.